Burning Rock Biotech (BNR) Retained Earnings (2019 - 2026)

Burning Rock Biotech's Retained Earnings history runs 8 years deep, the most recent figure standing at -$619.5 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 6.68% year-over-year to -$619.5 million; the TTM figure through Mar 2026 stood at -$619.5 million (down 6.68% YoY), while the FY2025 annual figure was $716.4 million, up 4.54% from the prior year.
• Retained Earnings for Q1 2026 stood at -$619.5 million, down from -$600.0 million in the prior quarter.
• The five-year high for Retained Earnings was $696.4 million in Q4 2024, with the low at -$619.5 million in Q1 2026.
• The 5-year median for Retained Earnings is -$506.0 million (2023), against an average of -$253.2 million.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings surged 336.39% in 2022, then sank 186.16% in 2025.
• Burning Rock Biotech's Retained Earnings stood at $644.4 million in 2022, then advanced by 4.52% to $673.5 million in 2023, then gained by 3.4% to $696.4 million in 2024, then plunged by 186.16% to -$600.0 million in 2025, then declined by 3.24% to -$619.5 million in 2026.
• Business Quant data shows BNR's Retained Earnings at -$619.5 million in Q1 2026, -$600.0 million in Q4 2025, and -$595.6 million in Q3 2025.